Zoladex implant in prostate cancer

Zoladex implant in prostate cancer

C023/4339 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.3MB

Downloadable file size: 2.8MB

Price image Pricing

Please login to use the price calculator


Credit: DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Caption: Zoladex implant in prostate cancer. Close-up of a doctor implanting a capsule of goserelin acetate, marketed under the name Zoladex, under the skin of a patient with prostate cancer. The capsule releases a controlled amount of the active drug over a set period of time. It is an LHRH (luteinising hormone-releasing hormone) blocker that is used to treat prostate cancer. It acts on the pituitary gland in the brain to prevent it producing luteinising hormone, the hormone that tells the testes to produce testosterone. In prostate tumours that are sensitive to testosterone, this causes the tumour to shrink. It does not provide a cure, but does increase life expectancy.

Release details: Model release not required. Property release not required.

Keywords: abnormal, adult, andrological, andrology, blocker, cancerous, capsule, caucasian, close-up, condition, controlled release, controlled-release, detail, device, disease, diseased, disorder, drug, drugs, equipment, goserelin acetate, healthcare, human body, implant, implanting, injecting, inserting, lhrh, luteinising hormone-releasing hormone, male, malignant, man, medical, medicine, neoplasm, oncological, oncology, pellet, people, person, pharmaceutical, pharmaceutics, pharmacological, pharmacology, prescription, prostate cancer, treatment, tumor, tumour, unhealthy, urological, urology, white, zoladex

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.